M. Kowalski, Z. Bartuzi, A. Bręborowicz, M. Czarnecka-Operacz, J. Kruszewski, M. Kulus, M. Moniuszko, M. Niedoszytko, M. Nittner-Marszalska, R. Nowicki, B. Rogala, M. Chałubiński
The document prepared by the expert panel of allergy/immunology specialists representing Polish Allergy Society intends to provide allergists with recommendations with respect to proper management of allergic patients during SARS-CoV-2 pandemics Allergist should aim at reducing patient’s social interactions by replacing face-to-face visits with communication via telephone or internet In parallel allergist is responsible for assuring that the patient is receiving proper care of underlying allergic disease The experts panel provides eighteen recommendations for management of patients with asthma and allergic diseases during pandemics, indicating that in majority of patients asthma treatment (including inhaled corticosteroids) and allergy treatment should be continued Specific recommendations for treatment with allergen immunotherapy and with biologics are discussed in details
{"title":"Position statement of expert panel of the Polish Allergology Society on the management of patients with bronchial asthma and allergic diseases during SARS-Cov-2 pandemics","authors":"M. Kowalski, Z. Bartuzi, A. Bręborowicz, M. Czarnecka-Operacz, J. Kruszewski, M. Kulus, M. Moniuszko, M. Niedoszytko, M. Nittner-Marszalska, R. Nowicki, B. Rogala, M. Chałubiński","doi":"10.5114/pja.2020.94606","DOIUrl":"https://doi.org/10.5114/pja.2020.94606","url":null,"abstract":"The document prepared by the expert panel of allergy/immunology specialists representing Polish Allergy Society intends to provide allergists with recommendations with respect to proper management of allergic patients during SARS-CoV-2 pandemics Allergist should aim at reducing patient’s social interactions by replacing face-to-face visits with communication via telephone or internet In parallel allergist is responsible for assuring that the patient is receiving proper care of underlying allergic disease The experts panel provides eighteen recommendations for management of patients with asthma and allergic diseases during pandemics, indicating that in majority of patients asthma treatment (including inhaled corticosteroids) and allergy treatment should be continued Specific recommendations for treatment with allergen immunotherapy and with biologics are discussed in details","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5114/pja.2020.94606","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48912595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
T. Zuberbier, Werner Aberer, R. Asero, A. H. A. Latiff, D. Baker, B. Ballmer-Weber, J. Bernstein, Carsten Bindslev-Jensen, Zenon Brzoza, R. Bedrikow, G. W. Canonica, Martin K. Church, T. Craig, Inna Vladimirovna Danilycheva, C. Dreßler, Luis Felipe Ensina, A. Giménez-Arnau, Kiran Godse, Margarida Gonçalo, C. Grattan, Jacques Hébert, Michihiro Hide, Allen P. Kaplan, A. Kapp, C. Katelaris, Emek Kocatürk, Kanokvalai Kulthanan, D. Larenas-Linnemann, T. Leslie, M. Magerl, P. Mathelier-Fusade, R. Y. Meshkova, Martin Metz, A. Nast, E. Nettis, H. Oude-Elberink, S. Rosumeck, Sarbjit S. Saini, Mario Sánchez-Borges, Peter Schmid-Grendelmeier, P. Staubach, Gordon L. Sussman, Elias Toubi, Gino A. Vena, Christian Vestergaard, B. Wedi, R. Werner, Zuotao Zhao, M. Maurer
T. Zuberbier1 , W. Aberer2, R. Asero3 , A. H. Abdul Latiff4, D. Baker5, B. Ballmer-Weber6, J. A. Bernstein7 , C. Bindslev-Jensen8, Z. Brzoza9 , R. Buense Bedrikow10, G. W. Canonica11, M. K. Church1, T. Craig12, I. V. Danilycheva13, C. Dressler14, L. F. Ensina15, A. Giménez-Arnau16, K. Godse17, M. Gonçalo18, C. Grattan19, J. Hebert20, M. Hide21 , A. Kaplan22, A. Kapp23, C. H. Katelaris24, E. Kocatürk25, K. Kulthanan26, D. Larenas-Linnemann27 , T. A. Leslie28, M. Magerl1, P. Mathelier-Fusade29, R. Y. Meshkova30, M. Metz1, A. Nast14, E. Nettis31, H. Oude-Elberink32, S. Rosumeck14, S. S. Saini33, M. Sánchez-Borges34, P. Schmid-Grendelmeier6, P. Staubach35, G. Sussman36, E. Toubi37, G. A. Vena38, C. Vestergaard39, B. Wedi23, R. N. Werner14, Z. Zhao40, M. Maurer1. Zaakceptowane przez następujące towarzystwa naukowe: AAAAI, AAD, AAIITO, ACAAI, AEDV, APAAACI, ASBAI, ASCIA, BAD, BSACI, CDA, CMICA, CSACI, DDG, DDS, DGAKI, DSA, DST, EAACI, EIAS, EDF, EMBRN, ESCD, GA2LEN, IAACI, IADVL, JDA, NVvA, MSAI, ÖGDV, PSA, RAACI, SBD, SFD, SGAI, SGDV, SIAAIC, SIDeMaST, SPDV, TSD, UNBB, UNEV i WAO*
{"title":"Wytyczne EAACI/GA2LEN/EDF/WAO dotyczące definicji, klasyfikacji, diagnostyki i leczenia pokrzywki","authors":"T. Zuberbier, Werner Aberer, R. Asero, A. H. A. Latiff, D. Baker, B. Ballmer-Weber, J. Bernstein, Carsten Bindslev-Jensen, Zenon Brzoza, R. Bedrikow, G. W. Canonica, Martin K. Church, T. Craig, Inna Vladimirovna Danilycheva, C. Dreßler, Luis Felipe Ensina, A. Giménez-Arnau, Kiran Godse, Margarida Gonçalo, C. Grattan, Jacques Hébert, Michihiro Hide, Allen P. Kaplan, A. Kapp, C. Katelaris, Emek Kocatürk, Kanokvalai Kulthanan, D. Larenas-Linnemann, T. Leslie, M. Magerl, P. Mathelier-Fusade, R. Y. Meshkova, Martin Metz, A. Nast, E. Nettis, H. Oude-Elberink, S. Rosumeck, Sarbjit S. Saini, Mario Sánchez-Borges, Peter Schmid-Grendelmeier, P. Staubach, Gordon L. Sussman, Elias Toubi, Gino A. Vena, Christian Vestergaard, B. Wedi, R. Werner, Zuotao Zhao, M. Maurer","doi":"10.5114/pja.2020.93827","DOIUrl":"https://doi.org/10.5114/pja.2020.93827","url":null,"abstract":"T. Zuberbier1 , W. Aberer2, R. Asero3 , A. H. Abdul Latiff4, D. Baker5, B. Ballmer-Weber6, J. A. Bernstein7 , C. Bindslev-Jensen8, Z. Brzoza9 , R. Buense Bedrikow10, G. W. Canonica11, M. K. Church1, T. Craig12, I. V. Danilycheva13, C. Dressler14, L. F. Ensina15, A. Giménez-Arnau16, K. Godse17, M. Gonçalo18, C. Grattan19, J. Hebert20, M. Hide21 , A. Kaplan22, A. Kapp23, C. H. Katelaris24, E. Kocatürk25, K. Kulthanan26, D. Larenas-Linnemann27 , T. A. Leslie28, M. Magerl1, P. Mathelier-Fusade29, R. Y. Meshkova30, M. Metz1, A. Nast14, E. Nettis31, H. Oude-Elberink32, S. Rosumeck14, S. S. Saini33, M. Sánchez-Borges34, P. Schmid-Grendelmeier6, P. Staubach35, G. Sussman36, E. Toubi37, G. A. Vena38, C. Vestergaard39, B. Wedi23, R. N. Werner14, Z. Zhao40, M. Maurer1. Zaakceptowane przez następujące towarzystwa naukowe: AAAAI, AAD, AAIITO, ACAAI, AEDV, APAAACI, ASBAI, ASCIA, BAD, BSACI, CDA, CMICA, CSACI, DDG, DDS, DGAKI, DSA, DST, EAACI, EIAS, EDF, EMBRN, ESCD, GA2LEN, IAACI, IADVL, JDA, NVvA, MSAI, ÖGDV, PSA, RAACI, SBD, SFD, SGAI, SGDV, SIAAIC, SIDeMaST, SPDV, TSD, UNBB, UNEV i WAO*","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5114/pja.2020.93827","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70477922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Inhalation drugs are the basis for both acute and chronic treatment of children with bronchial asthma. The choice of the method of aerosol therapy belongs to the physician who is responsible for the treatment and what should be considered is patient’s age together with understanding and willingness to follow orders, physical and mental capabilities, cooperation and the possibilities, skills and willingness of its guardians. To obtain a control of the disease it is necessary to provide training of the patient and his caregiver before starting the treatment and later during chronic treatment – regular control of the method of medication inhalation. It is equally important to transfer this knowledge to caregivers who will control the baby’s aerosol therapy at home. Their understanding and acceptance of a given inhalation system depends on therapeutic success. Aim of the research: This study aimed to obtain information on what methods of aerosol therapy are used in Polish pediatric patients with asthma, whether children and caregivers are using aerosol therapy techniques properly and what proportion of patients (and their guardians) has been trained by medical staff in this regard. Material and methods: Research was conducted in the form of a survey. Two versions of the questionnaire had been created (for parents of children aged 0–5 years and for children of 6 years and above). For the purpose of the study, parents and children completed the survey during the hospitalization in the Clinic of Allergology and Pneumonology of the Institute of Tuberculosis and Lung Diseases in Rabka-Zdroj from February 2016 to November 2018. One of the survey questions concerned the fact that parent or a child completed a Childhood Asthma Control Test (C-ACT) and other questions concerned the knowledge of the PEFR peak expiratory flow meter (“peak flow meter”, “pefrometer”). Results: Parents of 82 patients aged 0–5 (51 boys, 31 girls) and parents of 128 patients ≥ 6 years old (63 boys, 65 girls) took part in the survey. The data were obtained from the analysis of 210 questionnaires. The average age of diagnosis of bronchial asthma was 4 years and 7 months (younger group) and 5 years and 1 month (older group). Some of the questions were open (regarding the medicines and commercial names of inhalers and inhalation chambers), most in a closed form (single or multiple choice from several options). Over 93% of patients declared short-acting b-mimetic drugs (SABA). In the group of children aged 0–5 years, it was administered to patients on an ad hoc basis in nebulization (52.4%), and via pressure inhalers pMDI (62.2%) (several answers could be selected). In the group of children ≥ 6 years 34% of patients use SABA drugs in nebulization, 46.9% by pMDI and 18.8% by powder inhalers. In the group 0–5 years inhaled drugs in a chronic nebulization are taken by 52.4% of patients, whereas in the group of ≥ 6 years 25% take it in nebulization, 43% from the pMDI pressure i
{"title":"The use of inhaled drugs in the population of Polish pediatric patients suffering from bronchial asthma","authors":"Katarzyna Gregorczyk-Maślanka, R. Kurzawa","doi":"10.5114/pja.2020.93830","DOIUrl":"https://doi.org/10.5114/pja.2020.93830","url":null,"abstract":"Introduction: Inhalation drugs are the basis for both acute and chronic treatment of children with bronchial asthma. The choice of the method of aerosol therapy belongs to the physician who is responsible for the treatment and what should be considered is patient’s age together with understanding and willingness to follow orders, physical and mental capabilities, cooperation and the possibilities, skills and willingness of its guardians. To obtain a control of the disease it is necessary to provide training of the patient and his caregiver before starting the treatment and later during chronic treatment – regular control of the method of medication inhalation. It is equally important to transfer this knowledge to caregivers who will control the baby’s aerosol therapy at home. Their understanding and acceptance of a given inhalation system depends on therapeutic success. Aim of the research: This study aimed to obtain information on what methods of aerosol therapy are used in Polish pediatric patients with asthma, whether children and caregivers are using aerosol therapy techniques properly and what proportion of patients (and their guardians) has been trained by medical staff in this regard. Material and methods: Research was conducted in the form of a survey. Two versions of the questionnaire had been created (for parents of children aged 0–5 years and for children of 6 years and above). For the purpose of the study, parents and children completed the survey during the hospitalization in the Clinic of Allergology and Pneumonology of the Institute of Tuberculosis and Lung Diseases in Rabka-Zdroj from February 2016 to November 2018. One of the survey questions concerned the fact that parent or a child completed a Childhood Asthma Control Test (C-ACT) and other questions concerned the knowledge of the PEFR peak expiratory flow meter (“peak flow meter”, “pefrometer”). Results: Parents of 82 patients aged 0–5 (51 boys, 31 girls) and parents of 128 patients ≥ 6 years old (63 boys, 65 girls) took part in the survey. The data were obtained from the analysis of 210 questionnaires. The average age of diagnosis of bronchial asthma was 4 years and 7 months (younger group) and 5 years and 1 month (older group). Some of the questions were open (regarding the medicines and commercial names of inhalers and inhalation chambers), most in a closed form (single or multiple choice from several options). Over 93% of patients declared short-acting b-mimetic drugs (SABA). In the group of children aged 0–5 years, it was administered to patients on an ad hoc basis in nebulization (52.4%), and via pressure inhalers pMDI (62.2%) (several answers could be selected). In the group of children ≥ 6 years 34% of patients use SABA drugs in nebulization, 46.9% by pMDI and 18.8% by powder inhalers. In the group 0–5 years inhaled drugs in a chronic nebulization are taken by 52.4% of patients, whereas in the group of ≥ 6 years 25% take it in nebulization, 43% from the pMDI pressure i","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5114/pja.2020.93830","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70478124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Baut, Jadwiga Biela-Mazur, Anna Czyżewska-Dudek, R. Kurzawa
The article presents and summarizes the current state of knowledge about the management and treatment of allergic diseases in children during the SARS-CoV-2 pandemic Patients with allergic diseases do not show different symptoms of COVID-19 Children with atopy, like most children, undergo this infection mildly Current recommendations of Polish and international societies recommend continuing the therapy of allergic diseases to minimize the adverse effects of discontinuing treatment Continuing treatment with inhaled and oral glucocorticosteroids, antihistamines and anti-leukotriene drugs is not a risk factor for SARS-CoV-2 infection and should not be stopped Effective treatment of allergic rhinitis may have a positive effect on reducing the transmission of the virus For children with atopic dermatitis it is essential to use barrier preparations to care atopic skin more often to minimize side effects of excessive use of soaps and disinfectant fluids It is not recommended to start immunotherapy with inhaled allergens during a pandemic If there are conditions for epidemiologically safe continuation of specific immunotherapy, the sublingual form is preferred To minimize the risk of transmission of SARS-CoV-2 infection in medical facilities, telemedicine is the preferred method for continuing specialist care
{"title":"The management of allergic diseases in children during the SARS-CoV-2 pandemic","authors":"M. Baut, Jadwiga Biela-Mazur, Anna Czyżewska-Dudek, R. Kurzawa","doi":"10.5114/pja.2020.97661","DOIUrl":"https://doi.org/10.5114/pja.2020.97661","url":null,"abstract":"The article presents and summarizes the current state of knowledge about the management and treatment of allergic diseases in children during the SARS-CoV-2 pandemic Patients with allergic diseases do not show different symptoms of COVID-19 Children with atopy, like most children, undergo this infection mildly Current recommendations of Polish and international societies recommend continuing the therapy of allergic diseases to minimize the adverse effects of discontinuing treatment Continuing treatment with inhaled and oral glucocorticosteroids, antihistamines and anti-leukotriene drugs is not a risk factor for SARS-CoV-2 infection and should not be stopped Effective treatment of allergic rhinitis may have a positive effect on reducing the transmission of the virus For children with atopic dermatitis it is essential to use barrier preparations to care atopic skin more often to minimize side effects of excessive use of soaps and disinfectant fluids It is not recommended to start immunotherapy with inhaled allergens during a pandemic If there are conditions for epidemiologically safe continuation of specific immunotherapy, the sublingual form is preferred To minimize the risk of transmission of SARS-CoV-2 infection in medical facilities, telemedicine is the preferred method for continuing specialist care","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5114/pja.2020.97661","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70478329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Allergic rhinitis (AR) is a common condition. It is associated with allergens and an excessive immune response of the body. Previous therapies associated with AR are not free of side effects, including those involving the central nervous system. The main symptoms observed during the treatment of rhinitis are: drowsiness, seda-tion, drying of the mucosa, mood changes or impaired concentration and coordination. This work is a review that summarizes the current state of knowledge about the effect of current AR treatment on the inhibition of central nervous system activity.
{"title":"The effect of drugs used in allergic rhinitis on the central nervous system","authors":"G. Walkiewicz, M. Jankowska, R. Pawliczak","doi":"10.5114/pja.2020.102085","DOIUrl":"https://doi.org/10.5114/pja.2020.102085","url":null,"abstract":"Allergic rhinitis (AR) is a common condition. It is associated with allergens and an excessive immune response of the body. Previous therapies associated with AR are not free of side effects, including those involving the central nervous system. The main symptoms observed during the treatment of rhinitis are: drowsiness, seda-tion, drying of the mucosa, mood changes or impaired concentration and coordination. This work is a review that summarizes the current state of knowledge about the effect of current AR treatment on the inhibition of central nervous system activity.","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70477895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
SARS-CoV-2 pandemics increased research in the interaction of coronaviruses with human immune response Moreover, a detailed analysis of SARS-CoV-2 immune response might be helpful in vaccine development and delivering some other therapeutic approaches Several papers described SARS and MERS antiviral response Unfortunately, not all data derived from SARS and MERS studies could be directly applied to the SARS-CoV-2 immune response, its clinical course and severe COVID-19 pathology In this paper we are trying to summarize basic aspects of COVID-19 immunopathology focusing on immune response, pathogenesis of severe disease and the differences between SARS-CoV-2 and its predecessors Moreover, we are trying to outline possible therapeutic approaches including but not limited to vaccines All reviewed data have to be treated with caution Next months and years will generate more results helping us to deal with SARS-CoV-2, which will confirm or disprove current information and the understanding of COVID-19
{"title":"The immune response to SARS-CoV-2. Focus on severe COVID-19 pathogenesis","authors":"R. Pawliczak","doi":"10.5114/pja.2020.99243","DOIUrl":"https://doi.org/10.5114/pja.2020.99243","url":null,"abstract":"SARS-CoV-2 pandemics increased research in the interaction of coronaviruses with human immune response Moreover, a detailed analysis of SARS-CoV-2 immune response might be helpful in vaccine development and delivering some other therapeutic approaches Several papers described SARS and MERS antiviral response Unfortunately, not all data derived from SARS and MERS studies could be directly applied to the SARS-CoV-2 immune response, its clinical course and severe COVID-19 pathology In this paper we are trying to summarize basic aspects of COVID-19 immunopathology focusing on immune response, pathogenesis of severe disease and the differences between SARS-CoV-2 and its predecessors Moreover, we are trying to outline possible therapeutic approaches including but not limited to vaccines All reviewed data have to be treated with caution Next months and years will generate more results helping us to deal with SARS-CoV-2, which will confirm or disprove current information and the understanding of COVID-19","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70478512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Roxana Drygała, Klaudia Waszczykowska, Marta Węgierska
{"title":"A summary of novel biologics for asthma treatment","authors":"Roxana Drygała, Klaudia Waszczykowska, Marta Węgierska","doi":"10.5114/PJA.2020.96130","DOIUrl":"https://doi.org/10.5114/PJA.2020.96130","url":null,"abstract":"","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5114/PJA.2020.96130","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70478562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Horaczyńska-Wojtaś, Grażyna Gwizda, A. Marciniak, Grażyna Mielnik-Niedzielska
Introduction: Cough is an important defence reflex. Dry, non-productive cough continuing for at least 4–6 weeks may pose a diagnostic and therapeutic issue. Psychogenic cough is described as somatoform autonomic dysfunction and is diagnosed by excluding physical causes. Aim: To determine the aetiology and triggering mechanisms of habit cough and evaluate the treatment effects obtained with different types of psychotherapy. Material and methods: The study involved 30 children. Having excluded somatic disease foundation, psychological assessment was performed. Short-term psychotherapy and Ericksonian therapy were implemented. Results: The studied children suffered from sibling rivalry disorder, separation anxiety disorder of childhood, school anxiety, parental conflicts, communication failure, internal emotional conflicts, and lack of ability to cope with emotions and stress. Conclusions: Parents of psychologically troubled children presenting habit cough and other forms of somatoform autonomic dysfunction play an enormous role in the treatment process and should be active during psychotherapy.
{"title":"Habit cough in children. Specific symptoms and psychotherapy","authors":"A. Horaczyńska-Wojtaś, Grażyna Gwizda, A. Marciniak, Grażyna Mielnik-Niedzielska","doi":"10.5114/pja.2020.93832","DOIUrl":"https://doi.org/10.5114/pja.2020.93832","url":null,"abstract":"Introduction: Cough is an important defence reflex. Dry, non-productive cough continuing for at least 4–6 weeks may pose a diagnostic and therapeutic issue. Psychogenic cough is described as somatoform autonomic dysfunction and is diagnosed by excluding physical causes. Aim: To determine the aetiology and triggering mechanisms of habit cough and evaluate the treatment effects obtained with different types of psychotherapy. Material and methods: The study involved 30 children. Having excluded somatic disease foundation, psychological assessment was performed. Short-term psychotherapy and Ericksonian therapy were implemented. Results: The studied children suffered from sibling rivalry disorder, separation anxiety disorder of childhood, school anxiety, parental conflicts, communication failure, internal emotional conflicts, and lack of ability to cope with emotions and stress. Conclusions: Parents of psychologically troubled children presenting habit cough and other forms of somatoform autonomic dysfunction play an enormous role in the treatment process and should be active during psychotherapy.","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5114/pja.2020.93832","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70477885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
P. Adamczyk, B. Narożna, Aleksandra Szczepankiewicz, Anna Bręborowicz, Beata Pucher, Michał Kotowski, P. Żychowski, Jakub Sroczyński, Agata Kałużna-Młynarczyk, Jarosław Szydłowski
{"title":"Zmniejszona ekspresja microRNA-16 i microRNA-451a w przeroście migdałka gardłowego związana z alergią","authors":"P. Adamczyk, B. Narożna, Aleksandra Szczepankiewicz, Anna Bręborowicz, Beata Pucher, Michał Kotowski, P. Żychowski, Jakub Sroczyński, Agata Kałużna-Młynarczyk, Jarosław Szydłowski","doi":"10.5114/pja.2020.102086","DOIUrl":"https://doi.org/10.5114/pja.2020.102086","url":null,"abstract":"","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70477974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Procedures in allergy nursing play a critical role in the process of improving practical nursing skills A nurse’s diagnosis and treatment work as regards skin prick tests and allergen-specific immunotherapy is an essential part of nursing work with patients suffering from allergic diseases, which – according to statistics – are becoming epidemic in nature, with allergy being referred to as a disease of the 21st century The special value of this study is that it proposes certain procedures that should be adhered to at the time of the SARS-CoV-2 pandemic threat Procedures in allergy nursing play a major role in ensuring the accuracy of all nursing work, which involves skin prick tests and allergen-specific immunotherapy in this case If such procedures are adhered to, they allow for eliminating medical errors, which may result in adverse events on more than one occasion At a time when people are exposed to SARS-CoV-2 infection and other pathogens, the procedures are critical to ensuring the safety of nurses and their patients This is the first such study prepared as a precise, step-by-step description of the rules of the work of allergy nurses Diagnosis and treatment in the area of allergy nursing should be promoted widely and provided in accordance with accepted procedures
{"title":"Procedures in allergy nursing (specialized outpatient care)","authors":"Ewa Bodzak, E. Krzych-Fałta","doi":"10.5114/pja.2020.102087","DOIUrl":"https://doi.org/10.5114/pja.2020.102087","url":null,"abstract":"Procedures in allergy nursing play a critical role in the process of improving practical nursing skills A nurse’s diagnosis and treatment work as regards skin prick tests and allergen-specific immunotherapy is an essential part of nursing work with patients suffering from allergic diseases, which – according to statistics – are becoming epidemic in nature, with allergy being referred to as a disease of the 21st century The special value of this study is that it proposes certain procedures that should be adhered to at the time of the SARS-CoV-2 pandemic threat Procedures in allergy nursing play a major role in ensuring the accuracy of all nursing work, which involves skin prick tests and allergen-specific immunotherapy in this case If such procedures are adhered to, they allow for eliminating medical errors, which may result in adverse events on more than one occasion At a time when people are exposed to SARS-CoV-2 infection and other pathogens, the procedures are critical to ensuring the safety of nurses and their patients This is the first such study prepared as a precise, step-by-step description of the rules of the work of allergy nurses Diagnosis and treatment in the area of allergy nursing should be promoted widely and provided in accordance with accepted procedures","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70477649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：